The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the Jaws

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 5 SUPPL., 2009, Pages 85-95

  Carlson, Eric R ^a   Basile, John D ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; RISEDRONIC ACID; ZOLEDRONIC ACID;

ARTICLE; BONE RESECTION; DISEASE COURSE; FEMALE; HEALING; HUMAN; JAW OSTEONECROSIS; MAJOR CLINICAL STUDY; MALE; MANDIBLE RESECTION; MAXILLA RESECTION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; JAW; JAW DISEASES; MALE; ORAL SURGICAL PROCEDURES; OSTEONECROSIS; PROSPECTIVE STUDIES; REOPERATION; TREATMENT OUTCOME;

EID: 64249172682     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.01.006     Document Type: Article

References (37)

1. Migliorati C.A., Schubert M.M., Peterson D.E., et al. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone. An emerging oral complication of supportive cancer therapy. Cancer 104 (2005) 83
2. Rogers M.J., Watts D.J., and Russel R.G.G. Overview of bisphosphonates. Cancer 80 suppl (1997) 1652
3. Berenson J.R. Bisphosphonates in multiple myeloma. Cancer 80 (1997) 1661
4. Lipton A. Bisphosphonates and breast carcinoma. Cancer 80 (1997) 1668
5. McClung M.R. Bisphosphonates. Endocrinol Metab Clin North Am 32 (2003) 253
6. Naidu A., Dechow P.C., Spears R., et al. The effects of bisphosphonates on osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 (2008) 5
7. Santini D., Vincenzi B., Dicuonzo G., et al. Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 9 (2003) 2893
8. Landesberg R., Cozin M., Cremers S., et al. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg 66 (2008) 839
9. Ruggiero S.L., Mehrotra B., Rosenberg T.J., et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527
10. Etminan M., Aminzadeh K., Matthew I.R., et al. Use of oral bisphosphonates and the risk of aseptic osteonecrosis: A nested case-control study. J Rheumatol 35 (2008) 1
11. Koka S., Clarke B.L., Amin S., et al. Oral bisphosphonate therapy and osteonecrosis of the jaw: What to tell the concerned patient. Int J Prosthodont 20 (2007) 151
12. Kyrgidis A., Vahtsevanos K., and Koloutsos G. Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients. J Clin Oncol 26 (2008) 1
13. Wilkinson G.S., Kuo Y.F., Freeman J.L., et al. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis. J Natl Cancer Inst 99 (2007) 1016
14. Durie B.G.M., Katz M., and Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353 (2005) 99
15. Wang E.P., Kaban L.B., Strewler G.J., et al. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65 (2007) 1328
16. Bamias A., Kastritis E., Bamia C., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors. J Clin Oncol 23 (2005) 8580
17. Wessel J.H., Dodson T.B., and Zavras A. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A case-control study. J Oral Maxillofac Surg 66 (2008) 625
18. Zarynchanski R., Elphee E., Walton P., et al. Osteonecrosis of the jaw associated with pamidronate therapy. Am J Hematol 81 (2006) 73
19. Hewitt C., and Farah C.S. Bisphosphonate-related osteonecrosis of the jaws: A comprehensive review. J Oral Pathol Med 36 (2007) 319
20. Woo S.B., Hellstein J.W., and Kalmar J.R. Systematic review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753
21. Yarom N., Yahalom R., Shoshani Y., et al. Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing factors and treatment outcome. Osteoporosis Int 18 (2007) 1363
22. Marx R.E., Sawatari Y., Fortin M., et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567
23. In: Marx R.E. (Ed). Oral & Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws. History, Etiology, Prevention, and Treatment (2007), Chicago, IL, Quintessence Publishing
24. Ruggiero S.L. Osteonecrosis. In: Laskin D.M., and Abubaker A.O. (Eds). Decision Making in Oral and Maxillofacial Surgery (2007), Quintessence Publishing, Chicago, IL 228-229
25. Boonyapakorn T., Schirmer I., Reichart P.A., et al. Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 44 (2008) 857
26. Dodson T.B., Raje N.S., Caruso P.A., et al. Case 9-2008: A 65-year-old woman with a nonhealing ulcer of the jaw. N Engl J Med 358 (2008) 1283
27. Badros A., Weikel D., Salama A., et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol 24 (2006) 945
28. Marx R.E., Cillo J.E., and Ulloa J.J. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention and treatment. J Oral Maxillofac Surg 65 (2007) 2397
29. Freiberger J.J., Padilla-Burgos R., Chhoeu A.H., et al. Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: A case series. J Oral Maxillofac Surg 65 (2007) 1321
30. Vescovi P., Merigo E., Meleti M., et al. Bisphosphonate-associated osteonecrosis (BON) of the jaws: A possible treatment?. [letter]. J Oral Maxillofac Surg 64 (2006) 1460
31. Migliorati C.A., Casiglia J., Epstein J., et al. Managing the care of patients with bisphosphonate-associated osteonecrosis. An American Academy of Oral Medicine position paper. J Am Dent Assoc 136 (2005) 1658
32. Leite A.F., Figueiredo P.T., Melo N.S., et al. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 14
33. Nase J.B., and Suzuki J.B. Osteonecrosis of the jaw and oral bisphosphonate treatment. J Am Dent Assoc 137 (2006) 1115
34. Adornato M.C., Morcos I., and Rozanski J. The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors. J Am Dent Assoc 138 (2007) 971
35. Levin L., Laviv A., and Schwartz-Arad D. Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment. J Am Dent Assoc 138 (2007) 1218
36. Allen M.R., and Burr D.B. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 66 (2008) 987
37. Junquera L., and Gallego L. Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?. J Oral Maxillofac Surg 66 (2008) 1516